| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |